Scientists Develop Ingestible Robot That Delivers Insulin Without The Need For External Needles

Anytime the dispenses need to be refilled, the user takes one of the pills. The pill then ...

The robotic drug delivery system includes an implant near the intestines and magnetic capsules that would resupply the implant with medicine. (The Biorobotics Institute, Scuola Superiore Sant’ Anna)

Anytime the dispenses need to be refilled, the user takes one of the pills. The pill then travels down their digestive system until it reaches the point where the device is implanted near their small intestine. The device then uses the power of magnets to rotate the capsule into position and then punctures it with a retractable needle and pumps the refill of insulin into a reservoir, reports EndGadget.

One of the most convenient things about this system is that the dispenser charges wirelessly, limiting the number of interventions a doctor needs to maintain the device. Once the capsule is empty, it continues its travel down the digestive system until the user releases it with his stool.

Read more: This Coin-Sized Smart Patch Delivers Insulin as Blood Sugar Increases

The researchers tested their device on three diabetic pigs. They found the system could successfully manage their insulin levels for several hours. In some instances, they found bodily fluids from the pigs would leak into the robot. So as a next step, the team is working on sealing the device better.

Sam Draper
August 20, 2021

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Breakthrough Microfluidic Device Detects Cancer Faster and Less Invasively

A device that could allow doctors to detect cancer quickly.

Physical Activity and Wearables – Prevention, Treatment and Rehabilitation

By providing patients with an instant biofeedback, wearables not only have the possibility...

Global Launch of Ks2 Smartwatch from Kieslect

Kieslect celebrated the global launch of the Kieslect Ks2, with dual Core, Triple Speed technology.

Fitbit's Q2 results show weak smartwatch sales due to weak Versa Lite sales

Fitbits revenue and device sales were up but the average price of the devices was down.
Discover more